切换至 "中华医学电子期刊资源库"

中华老年病研究电子杂志 ›› 2024, Vol. 11 ›› Issue (01) : 24 -29. doi: 10.3877/cma.j.issn.2095-8757.2024.01.005

临床研究

1990—2019年我国75岁及以上居民高收缩压所致脑卒中疾病负担及趋势分析
罗峥1, 张蔚1, 徐晓云1, 史楠1, 张燕1, 赵梅珍1, 刘康永1, 李小攀2,()   
  1. 1. 201318 上海健康医学院附属周浦医院神经内科
    2. 200032 上海,复旦大学附属中山医院健康管理中心
  • 收稿日期:2023-11-09 出版日期:2024-02-28
  • 通信作者: 李小攀
  • 基金资助:
    上海市浦东新区卫生健康委员会特色专病项目(PWZzb2022-20); 上海健康医学院院级教学课题(ZPJXKT-21-11); 上海市卫生健康委员会面上项目(202150015); 上海市浦东新区卫生健康委员会特色学科建设项目(PWYts2021-02)

Changes in disease burden of stroke due to high systolic blood pressure in residents aged 75 years and above in China, 1990-2019

Zheng Luo1, Wei Zhang1, Xiaoyun Xu1, Nan Shi1, Yan Zhang1, Meizhen Zhao1, Kangyong Liu1, Xiaopan Li2,()   

  1. 1. Neurology Department, Zhoupu Hospital Affiliated to Shanghai Medical College, Pudong District, Shanghai 201318, China
    2. Department of Health Management Center, Zhongshan Hospital of Fudan University, Shanghai 200032, China
  • Received:2023-11-09 Published:2024-02-28
  • Corresponding author: Xiaopan Li
引用本文:

罗峥, 张蔚, 徐晓云, 史楠, 张燕, 赵梅珍, 刘康永, 李小攀. 1990—2019年我国75岁及以上居民高收缩压所致脑卒中疾病负担及趋势分析[J]. 中华老年病研究电子杂志, 2024, 11(01): 24-29.

Zheng Luo, Wei Zhang, Xiaoyun Xu, Nan Shi, Yan Zhang, Meizhen Zhao, Kangyong Liu, Xiaopan Li. Changes in disease burden of stroke due to high systolic blood pressure in residents aged 75 years and above in China, 1990-2019[J]. Chinese Journal of Geriatrics Research(Electronic Edition), 2024, 11(01): 24-29.

目的

分析我国75岁及以上老年人高收缩压所致脑卒中疾病负担及其趋势。

方法

整理2019年全球疾病负担研究(GBD 2019)数据,采用Joinpoint回归模型对1990—2019年我国75岁及以上老年人高收缩压所致脑卒中死亡率和伤残调整生命年(DALY)进行分析。

结果

1990—2019年,我国75岁及以上居民因高收缩压导致的脑卒中死亡数自221 019人上升至552 179人,但粗死亡率和DALY率分别从806.84/105和10 694.21/105下降至611.01/105和7 967.83/105。趋势分析发现,我国75岁及以上居民因高收缩压导致的脑卒中粗死亡率逐年下降0.86%,男性逐年下降0.36%,女性逐年下降1.38%(Z=-6.72、-3.08、-9.43,P<0.01);DALY率逐年下降0.88%,男性DALY率逐年下降0.45%,女性DALY率逐年下降1.33%(Z=-7.16、-3.88、-9.91,P<0.01);75岁以上老年人因高血压所致脑卒中粗死亡率和DALY率均高于65~75(不包含75)岁老年人,且DALY率降速较低(分别为-0.88%和-1.24%)。我国75岁及以上居民因高收缩压导致的脑卒中DALY率高于高、中、低社会人口指数(SDI)国家或地区,逐年下降百分比低于高SDI国家或地区,但高于中、低SDI国家或地区(中国:-0.88%,高SDI国家或地区:-3.57%,中等SDI国家或地区:-0.69%,低SDI国家或地区:-0.67%)。

结论

我国75岁以上老年人因高收缩压导致的脑卒中疾病负担重且降速慢,应深入开展高龄险人群精准健康管理研究,以实现健康老龄化目标。

Objective

To analyze the disease burden of stroke due to high systolic blood pressure and its trend in residents aged 75 years and above in China.

Methods

Data from the Global Burden of Disease Study 2019 (GBD 2019) were collected and Joinpoint regression model was used to analyze the mortality rate and disability-adjusted life year (DALY) of stroke due to high systolic blood pressure in elderly people aged 75 years and above in China from 1990 to 2019.

Results

From 1990 to 2019, the number of stroke deaths due to high systolic blood pressure in residents aged 75 years and above increased from 221 019 to 552 179, but the crude death rate and DALY rate declined from 806.84/105 and 10 694.21/105 to 611.01/105 and 7 967.83/105, respectively. Trend analysis found that the crude stroke mortality rate due to high systolic blood pressure among residents aged 75 years and above in China decreased by 0.86% per year, with 0.36% per year in men and 1.38% per year in women (Z=-6.72, -3.08, -9.43; P < 0.01); and the DALY rate decreased by 0.88% per year, with 0.45% per year in men and 1.33% per year in women (Z=-7.16, -3.88, -9.91; P < 0.01). Crude mortality and DALY rates for stroke due to hypertension were higher in residents aged 75 years and above compared with those between 65-<75 years old, and the DALY rate in residents aged 75 years and above decline at a lower rate (-0.88% and -1.24%, respectively). The DALY rate of stroke due to high systolic blood pressure among residents aged 75 years and above in China was higher than that of high, medium, and low social demographic index (SDI) countries or regions, and the percentage of year-on-year decline was lower than that of high SDI countries or regions, but higher than that of medium and low SDI countries or regions (China: -0.88%, high SDI countries or regions: -3.57%, medium SDI countries or regions: -0.69%, low SDI countries or regions: -0.67%).

Conclusion

The disease burden of stroke due to high systolic blood pressure in China's elderly is high and slow to decline, and research on precise health management of the elderly risk group should be carried out in depth to achieve the goal of healthy aging.

图1 1990—2019年中国高收缩压所致脑卒中的粗死亡率和DALY率变化趋势。1A:总人群、65~75(不含75)岁和≥75岁人群粗死亡率;1B:总人群、65~75(不含75)岁和≥75岁人群DALY率注:DALY指伤残调整生命年
图2 1990—2019年中国75岁及以上居民高收缩压所致脑卒中的疾病负担变化趋势Joinpoint回归分析结果
图3 1990—2019年中国与不同社会人口指数地区75岁及以上居民高收缩压所致脑卒中疾病负担的变化趋势。3A:粗死亡率变化趋势图;3B:DALY率变化趋势图注:SDI指社会人口指数;DALY指伤残调整生命年
[1]
Schwartz L, Anteby R, Klang E, et al. Stroke mortality prediction using machine learning: Systematic review[J]. J Neurol Sci, 2023, 444:120529.
[2]
Wang YJ, Li ZX, Gu HQ, et al. China Stroke Statistics Writing Committee. China stroke statistics: An update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations[J]. Stroke Vasc Neurol, 2022, 7(5):415-450.
[3]
Ma Q, Li R, Wang L, et al. Temporal trend and attributable risk factors of stroke burden in China, 1990-2019: An analysis for the global burden of disease study 2019[J/OL]. Lancet Public Health, 2021, 6:e897-906.
[4]
Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet, 2020, 396(10258):1204-1222.
[5]
Wu S, Wu B, Liu M, et al. China Stroke Study Collaboration. Stroke in China: Advances and challenges in epidemiology, prevention, and management[J]. Lancet Neurol, 2019, 18(4):394-405.
[6]
Chao BH, Yan F, Hua Y, et al. Stroke prevention and control system in China: CSPPC-Stroke Program[J]. Int J Stroke, 2021, 16(3):265-272.
[7]
Lin X, Wang H, Rong X, et al. Exploring stroke risk and prevention in China: Insights from an outlier[J]. Aging (Albany NY), 2021, 13(11):15659-15673.
[8]
Feigin VL, Nguyen G, Cercy K, et al. GBD 2016 Lifetime Risk of Stroke Collaborators. Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016[J]. N Engl J Med, 2018, 379(25):2429-2437.
[9]
Wang W, Jiang B, Sun H, et al. NESS-China Investigators. Prevalence, incidence, and mortality of stroke in China: Results from a nationwide population-based survey of 480 687 adults[J]. Circulation, 2017, 135(8):759-771.
[10]
Zhao Y, Hua X, Ren X, et al. Increasing burden of stroke in China: A systematic review and meta-analysis of prevalence, incidence, mortality, and case fatality[J]. Int J Stroke, 2023, 18(3):259-267.
[11]
Wang L, Peng W, Zhao Z, et al. Prevalence and treatment of diabetes in China, 2013-2018[J]. JAMA, 2021, 326(24):2498-2506.
[12]
Wang L, Zhou B, Zhao Z, et al. Body-mass index and obesity in urban and rural China: Findings from consecutive nationally representative surveys during 2004-2018[J]. Lancet, 2021, 398(10294):53-63.
[13]
Hu S, Cui B, Mlynash M, et al. Stroke epidemiology and stroke policies in China from 1980 to 2017: A systematic review and meta-analysis[J]. Int J Stroke, 2020, 15(1):18-28.
[14]
Qi J, Adair T, Chowdhury HR, et al. Estimating causes of out-of-hospital deaths in China: Application of SmartVA methods[J]. Popul Health Metr, 2021, 19(1):25.
[15]
马林,巢宝华,曹雷,等.2007—2017年中国脑卒中流行趋势及特征分析[J/CD].中华脑血管病杂志(电子版)202014(5):253-258.
[16]
王淼,范美娟,张黎波.2007—2019年天津市河西区脑卒中死亡流行特征和趋势分析[J].上海预防医学202133(11):1001-1006.
[17]
Yang G, Kong L, Zhao W, et al. Emergence of chronic non-communicable diseases in China[J]. Lancet, 2008, 372(9650):1697-705.
[18]
Wu S, Wu B, Liu M, et al. China Stroke Study Collaboration. Stroke in China: Advances and challenges in epidemiology, prevention, and management[J]. Lancet Neurol, 2019, 18(4):394-405.
[19]
王陇德,彭斌,张鸿祺,等.《中国脑卒中防治报告2020》概要[J].中国脑血管病杂志202219(2):136-144.
[20]
Satoh M, Ohkubo T, Asayama K, et al. EPOCH-JAPAN Research Group. Lifetime risk of stroke and coronary heart disease deaths according to blood pressure level: EPOCH-JAPAN (evidence for cardiovascular prevention from observational cohorts in Japan)[J]. Hypertension, 2019, 73(1):52-59.
[21]
Tu WJ, Zhao Z, Yin P, et al. Estimated burden of stroke in China in 2020[J/OL]. JAMA Netw Open, 2023, 6(3):e231455.
[22]
Chen X, Liu L, Liu M, et al. Hypertensive retinopathy and the risk of stroke among hypertensive adults in China[J]. Invest Ophthalmol Vis Sci, 2021, 62(9):28.
[23]
Markus HS, Leung T. Stroke in China[J]. Int J Stroke, 2023, 18(3):256-258.
[24]
Yang P, Song L, Zhang Y, et al. Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): A multicentre, open-label, blinded-endpoint, randomised controlled trial[J]. Lancet, 2022, 400(10363):1585-1596.
[1] 孙剑玥, 黄瑾, 沈逸冕, 周超群, 程记伟. 重症脑卒中后呼吸机相关肺炎临床及病原学特点[J]. 中华实验和临床感染病杂志(电子版), 2024, 18(01): 11-18.
[2] 徐金, 龙耀斌, 郑继青. 头针联合辣椒素治疗脑卒中后慢性期吞咽障碍的临床疗效分析[J]. 中华脑科疾病与康复杂志(电子版), 2024, 14(02): 80-85.
[3] 高振轩, 谢晨, 曹绍东, 甘中伟, 周倍, 罗朝川, 王子齐, 葛煜彤, 张伟光. 高分辨率核磁共振在颅颈大动脉狭窄介入治疗中的临床应用进展[J]. 中华脑科疾病与康复杂志(电子版), 2024, 14(02): 112-119.
[4] 李旺俊, 王云霞. 抽吸联合支架取栓对超时间窗后循环缺血性脑卒中患者脑血灌注的影响[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(06): 352-357.
[5] 王增龙, 顾梅, 杭宇, 刘圣, 施海彬, 包建英. 急性大血管闭塞性脑卒中患者血管内治疗后吞咽障碍发生的危险因素分析[J]. 中华介入放射学电子杂志, 2024, 12(01): 10-14.
[6] 邓晨阳, 侯淑肖. 中青年脑卒中患者抗逆力相关研究进展及启示[J]. 中华脑血管病杂志(电子版), 2024, 18(02): 97-103.
[7] 华美芳, 陈莉, 张峰林, 刘忠. 出血性脑卒中术后并发肺部感染的影响因素分析[J]. 中华脑血管病杂志(电子版), 2024, 18(02): 110-114.
[8] 王丽萍, 聂玉琴, 朱爱丽. 盆底肌电刺激联合生物反馈疗法在女性卒中后尿失禁患者中的应用价值[J]. 中华脑血管病杂志(电子版), 2024, 18(02): 129-133.
[9] 左舜之, 张志强, 肖云燚, 江娇, 何亚玲, 刘羽. 针刺结合重复经颅磁刺激改善脑卒中患者单侧忽略的效果[J]. 中华脑血管病杂志(电子版), 2024, 18(02): 134-139.
[10] 胡秀朝, 徐霁华, 米荷音, 郝咏刚, 秦伟, 王韵. 高分辨磁共振成像在颈部动脉夹层致脑卒中诊断及随访研究中的价值[J]. 中华脑血管病杂志(电子版), 2024, 18(02): 140-144.
[11] 赖敏, 林碧玲, 王亚文, 林玉禧, 欧开雅. 中青年脑卒中患者重返工作的影响因素分析及预测模型构建[J]. 中华脑血管病杂志(电子版), 2024, 18(02): 145-152.
[12] 李淑敏, 侯淑肖. 脑卒中照顾者获益感研究的范围综述[J]. 中华脑血管病杂志(电子版), 2024, 18(02): 157-163.
[13] 王晖, 李丽, 周宝华, 杨琼, 李葆华, 罗永梅. 间歇管饲在脑卒中吞咽障碍患者康复中的应用进展[J]. 中华脑血管病杂志(电子版), 2024, 18(02): 177-180.
[14] 罗婷, 邱令智, 易东, 鄢华. 线粒体功能障碍与心血管疾病、缺血性脑卒中及慢性肾脏病关系的研究进展[J]. 中华脑血管病杂志(电子版), 2024, 18(01): 60-63.
[15] 沈洁, 赵弘轶, 黄勇华. 光生物调节技术在脑卒中治疗中的研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(06): 613-616.
阅读次数
全文


摘要